Biosynth Carbosynth Acquires Pepscan
July 4, 2022
Biosynth Carbosynth, a KKR- and Ampersand-backed supplier of materials to the life-sciences industry, has acquired Pepscan, a Netherlands-based peptide discovery, optimization and GMP peptide manufacturing specialist. The deal adds Pepscan’s proprietary CLIPS technology and epitope-mapping capabilities to Biosynth’s peptide capabilities (including vivitide) to form a new global Peptide division serving pharma, biotech, diagnostics and cosmetics customers.
- Buyers
- Biosynth Carbosynth
- Targets
- Pepscan
- Platforms
- Biosynth Carbosynth
- Industry
- Biotechnology
- Location
- Flevoland, Netherlands
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.